Damien Kee

Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Jessie Villanueva, Adina Vultur, John Tayu Lee et al. · Cancer Cell · 2010 · 1.2K citations · Full text

Medicine, Cancer Biology, Oncology +13

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Medicine, Dermatology, Oncology +13

<i>RAS</i> Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

Patrick A. Oberholzer, Damien Kee, Piotr Dziunycz et al. · Journal of Clinical Oncology · 2011 · 381 citations · Full text

Medicine, Oncology, Pharmacology +16

Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study

Antoni Ribas, René González, Anna C. Pavlick et al. · The Lancet Oncology · 2014 · 295 citations

Medicine, Oncology, Pharmacology +12

Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers

Oliver Klein, Damien Kee, Adnan Nagrial et al. · JAMA Oncology · 2020 · 229 citations · Full text

Medicine, Oncology, Pharmacotherapy +15